Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Q Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Q Bio

Q Bio

Series B

Q Bio pioneers in providing a universally accessible Clinical Digital Twin Platform.

HQ
San Carlos, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Q Bio, founded with the mission to build the first universally accessible Clinical Digital Twin Platform, offers innovative health technology solutions. Their core products include the Gemini Digital Twin Platform, which synthesizes digital twins and generates health forecasts, the Mark I full-body scanner, and the Anatomical Foundation Model (AFM) for whole-body radiology. Q Bio aims to revolutionize healthcare by making advanced health diagnostics and monitoring available to everyone.

Notable affiliated individuals and investors include industry experts and leading venture capital firms, though specific names are not provided. Key achievements include the development of the fastest full-body scanner and a foundational AI model for radiology. Q Bio's impact lies in its potential to democratize access to advanced health diagnostics, enabling proactive health management and personalized medical care on a global scale.

Q Bio - Similar Companies

Quantivly logo

Quantivly

quantivly.com

Q BioMed logo

Q BioMed

qbiomed.com

Probius logo

Probius

probius.bio

QbDVision logo

QbDVision

qbdvision.com

Qvin logo

Qvin

qvin.com

QTC Care logo

QTC Care

qtclinics.com

BloodQ logo

BloodQ

bloodq.com

BioQ Pharma logo

BioQ Pharma

bioqpharma.com

Quantum Diamond Technologies logo

Quantum Diamond Technologies

Q32 Bio logo

Q32 Bio

q32bio.com

Qrativ logo

Qrativ

qrativ.bio

Bioniq Health logo

Bioniq Health

Quantgene logo

Quantgene

quantgene.com

Twin Health logo

Twin Health

twinhealth.com

Qure4u logo

Qure4u

qure4u.com

Q Bio - Quick Facts

Who are Q Bio's competitors?

Companies similar to Q Bio include Quantivly, Q BioMed, Probius and QbDVision.

When was Q Bio founded?

Q Bio was founded in 2015.

Where is Q Bio's headquarters located?

Q Bio's headquarters is located in San Carlos, CA, US.

When was Q Bio's last funding round?

Q Bio's most recent funding round was for $40M (USD) in February 2020.

How much has Q Bio raised to-date?

As of Feb 20, 2020, Q Bio has raised a total of $64M (USD).

How many employees does Q Bio have?

Q Bio has 50 employees as of Feb 4, 2024.

Q Bio - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Digital Twin
  • Health Platform
Tags
  • AI Operations
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software